Trending
Stocks.org
You are at:»»Gainers NASDAQ: Cytokinetics (NASDAQ:CYTK), Dyax Corp. (NASDAQ:DYAX), Supercom (NASDAQ:SPCB), Amarin Corporation plc (ADR) (NASDAQ:AMRN)

Gainers NASDAQ: Cytokinetics (NASDAQ:CYTK), Dyax Corp. (NASDAQ:DYAX), Supercom (NASDAQ:SPCB), Amarin Corporation plc (ADR) (NASDAQ:AMRN)

627
By on BioPharma, Consumer Staples, Economy, Energy & Solar, S&P 500, Street Watch, Technology & Software

Needham views the risk/reward for shares of Cytokinetics Inc. (NASDAQ:CYTK) as favourable into the tirasemtiv Phase IIb trial data likely to be announced at the American Academy of Neurology meeting in late April. On last trading day Cytokinetics, Inc. (NASDAQ:CYTK) ended up 10.11%higher to close at $9.37 while trading in the range of $8.46 – $9.39. Its return on assets (ROA) is -40.80% while return on investment (ROI) is -62.30%.Cytokinetics, Inc. (NASDAQ:CYTK) monthly performance is -6.30%.

Analysts at RBC Capital assumed coverage on shares of Dyax Corp. (NASDAQ:DYAX) in a research report issued to clients and investors on Tuesday, TheFlyOnTheWall.com reports. The firm set an “outperform” rating and a $15.00 price target on the stock. RBC Capital’s target price points to a potential upside of 81.16% from the stock’s previous close. Dyax Corp. (NASDAQ:DYAX) in last trading activity ended up at $8.71 with day range of $8.11 – $8.79. Company weekly performance is -6.94% while its quarterly performance stands at 13.41%.Dyax Corp. (NASDAQ:DYAX) is -20.75% away from its 52 week high.

Fiscal 2013 was generally a rewarding year for Supercom Ltd (NASDAQ:SPCB) from a financial standpoint, the CEO Arie Trabelsi observed when the company released financial results today. Supercom Ltd (NASDAQ:SPCB) belongs to Technology sector with market capitalization of 55.85 million. In last trading activity company’s stock closed at $6.42 while opening price was $7.00.

Amarin Co. plc (NASDAQ:AMRN)‘s stock had its “hold” rating reiterated by investment analysts at Aegis in a note issued to investors on Friday, Stock Ratings News reports. On Thursday shares of Amarin Corporation plc (ADR) (NASDAQ:AMRN) opened at $1.74 and closed at $1.85. This year Company’s Earnings per Share (EPS) growth is -1.03 and next year’s estimated EPS growth is 46.80%. Analysts mean target price for Amarin Corporation plc (ADR) (NASDAQ:AMRN) is $2.35.

Get Free Updates and Stock Alerts!



*We only send one email per week
Share.

Related Posts

Get Winning Stock Alerts!

Our track record speaks for itself! Our last 7 alerts have delivered combined gains in excess of 300% and there are no signs of slowing down. Join UltimateStockAlerts.com now before you miss out on our next big runner!

We will never sell or share your information.
Close